10-Q/A Filing

22ND CENTURY GROUP, INC. CIK: 1347858 Q2 2011

Filing Information

Form Type	10-Q/A
Accession Number	`0001144204-11-050611`
Period End Date	20110630
Filing Date	20110830
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	xxii-20110630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 63 Cash Flow Statement 68 Stockholders Equity 11 Comprehensive Income 2

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Authorized, preferred shares	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Authorized, preferred shares	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred shares, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred shares, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Cash	`Cash`	$86.58K	USD	Point-in-time
Cash	`Cash`	$158.00	USD	Point-in-time
Cash	`Cash`	$33.24K	USD	Point-in-time
Authorized, common shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Authorized, common shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Cash	`Cash`	$310.00	USD	Point-in-time
Common shares, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common shares, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$150.00K	USD	Point-in-time
Issued, preferred shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Grant receivable	`GrantsReceivableCurrent`	$223.54K	USD	Point-in-time
Issued, preferred shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Outstanding, preferred shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	$14.33K	USD	Point-in-time
Outstanding, preferred shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Issued, common shares	`CommonStockSharesIssued`	27.21M	shares	Point-in-time
Inventory	`InventoryNet`	$308.66K	USD	Point-in-time
Issued, common shares	`CommonStockSharesIssued`	16.00M	shares	Point-in-time
Inventory	`InventoryNet`	$916.16K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$211.72K	USD	Point-in-time
Outstanding, common shares	`CommonStockSharesOutstanding`	16.00M	shares	Point-in-time
Outstanding, common shares	`CommonStockSharesOutstanding`	27.21M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$150.19K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$744.23K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.32M	USD	Point-in-time
Patent and trademark costs, net	`IntangibleAssetsNetExcludingGoodwill`	$1.43M	USD	Point-in-time
Patent and trademark costs, net	`IntangibleAssetsNetExcludingGoodwill`	$1.47M	USD	Point-in-time
Office furniture and fixtures, net	`PropertyPlantAndEquipmentNet`	$4.43K	USD	Point-in-time
Deferred private placement costs	`DeferredCosts`	$587.13K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$1.53K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$1.53K	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$1.44M	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$2.06M	USD	Point-in-time
Total assets	`Assets`	$2.80M	USD	Point-in-time
Total assets	`Assets`	$2.76M	USD	Point-in-time
Demand bank loans	`ShortTermBankLoansAndNotesPayable`	$174.93K	USD	Point-in-time
Demand bank loans	`ShortTermBankLoansAndNotesPayable`	$174.93K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.21M	USD	Point-in-time
Accrued interest payable to shareholders	`InterestPayableCurrent`	$11.72K	USD	Point-in-time
Accrued interest payable to shareholders	`InterestPayableCurrent`	$190.98K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$227.72K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$190.39K	USD	Point-in-time
Deferred grant revenue	`DeferredRevenueCurrent`	$80.00K	USD	Point-in-time
Deferred grant revenue	`DeferredRevenueCurrent`	$223.54K	USD	Point-in-time
Notes payable to shareholders, net of unamortized discount	`NotesPayableRelatedPartiesClassifiedCurrent`	$1.10M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$123.22K	USD	Point-in-time
Due to related party	`DueToRelatedPartiesCurrent`	$6.94K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$4.51K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$3.20K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.82M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.79M	USD	Point-in-time
Long-term notes, less current portion	`LongTermLoansPayable`	$627.00K	USD	Point-in-time
Long-term notes, less current portion	`LongTermLoansPayable`	$65.56K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$3.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.89M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.48M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
0 preferred shares	`PreferredStockValue`	-	USD	Point-in-time
0 preferred shares	`PreferredStockValue`	-	USD	Point-in-time
27,209,646 common shares (16,000,000 at December 31, 2010)	`CommonStockValue`	$273.00	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapital`	$4.72M	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapital`	$3.60M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-7.44M	USD	Point-in-time
Non-controlling interest - consolidated subsidiary	`MinorityInterest`	$-1.84K	USD	Point-in-time
Non-controlling interest - consolidated subsidiary	`MinorityInterest`	$-134.00	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.73M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time
Total liabilities and shareholders' deficit	`LiabilitiesAndStockholdersEquity`	$2.80M	USD	Point-in-time
Total liabilities and shareholders' deficit	`LiabilitiesAndStockholdersEquity`	$2.76M	USD	Point-in-time

Income Statement 63 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	$272.27K	USD	2 Qtrs
Revenue	`SalesRevenueNet`	$154.81K	USD	1 Quarter
Revenue	`SalesRevenueNet`	$1.80K	USD	2 Qtrs
Revenue	`SalesRevenueNet`	$1.80K	USD	1 Quarter
Other Income - Therapeutic Grant Credit	`RevenueFromGrants`	$94.32K	USD	1 Quarter
Other Income - Therapeutic Grant Credit	`RevenueFromGrants`	$143.54K	USD	2 Qtrs
Total revenue	`Revenues`	$249.13K	USD	1 Quarter
Total revenue	`Revenues`	$1.80K	USD	1 Quarter
Total revenue	`Revenues`	$1.80K	USD	2 Qtrs
Total revenue	`Revenues`	$415.81K	USD	2 Qtrs
Costs of goods sold	`CostOfGoodsSold`	$1.00K	USD	1 Quarter
Costs of goods sold	`CostOfGoodsSold`	$1.00K	USD	2 Qtrs
Costs of goods sold	`CostOfGoodsSold`	$93.65K	USD	2 Qtrs
Costs of goods sold	`CostOfGoodsSold`	$46.65K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$120.02K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$797.05K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$215.44K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$580.76K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$244.66K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$604.30K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$930.39K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$148.56K	USD	1 Quarter
Sales and marketing costs	`SellingAndMarketingExpense`	$230.70K	USD	2 Qtrs
Sales and marketing costs	`SellingAndMarketingExpense`	$59.34K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$44.23K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$80.93K	USD	2 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$87.80K	USD	2 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$41.07K	USD	1 Quarter
Costs and Expenses, Total	`CostsAndExpenses`	$1.34M	USD	1 Quarter
Costs and Expenses, Total	`CostsAndExpenses`	$310.65K	USD	1 Quarter
Costs and Expenses, Total	`CostsAndExpenses`	$2.14M	USD	2 Qtrs
Costs and Expenses, Total	`CostsAndExpenses`	$542.04K	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-540.24K	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-308.85K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.09M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.72M	USD	2 Qtrs
Shareholders	`InterestExpenseRelatedParty`	$18.78K	USD	2 Qtrs
Shareholders	`InterestExpenseRelatedParty`	$121.40K	USD	2 Qtrs
Shareholders	`InterestExpenseRelatedParty`	$6.63K	USD	1 Quarter
Shareholders	`InterestExpenseRelatedParty`	$63.38K	USD	1 Quarter
Other	`InterestExpenseOther`	$12.41K	USD	2 Qtrs
Other	`InterestExpenseOther`	$28.48K	USD	2 Qtrs
Other	`InterestExpenseOther`	$10.55K	USD	1 Quarter
Other	`InterestExpenseOther`	$12.87K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.75M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-1.10M	USD	1 Quarter
Net loss	`ProfitLoss`	$-385.10K	USD	1 Quarter
Net loss	`ProfitLoss`	$-690.12K	USD	2 Qtrs
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.00	USD	2 Qtrs
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.71K	USD	2 Qtrs
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.46K	USD	1 Quarter
Net loss attributed to common shareholders	`NetIncomeLoss`	$-690.11K	USD	2 Qtrs
Net loss attributed to common shareholders	`NetIncomeLoss`	$-385.10K	USD	1 Quarter
Net loss attributed to common shareholders	`NetIncomeLoss`	$-1.10M	USD	1 Quarter
Net loss attributed to common shareholders	`NetIncomeLoss`	$-1.75M	USD	2 Qtrs
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	2 Qtrs
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	2 Qtrs
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	25.56M	shares	2 Qtrs
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	9.15M	shares	2 Qtrs
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	11.19M	shares	1 Quarter
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	27.20M	shares	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.75M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-1.10M	USD	1 Quarter
Net loss	`ProfitLoss`	$-385.10K	USD	1 Quarter
Net loss	`ProfitLoss`	$-690.12K	USD	2 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$44.23K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$80.93K	USD	2 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$87.80K	USD	2 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$41.07K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$21.55K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$80.79K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$2.67K	USD	2 Qtrs
Equity based employee compensation expense	`ShareBasedCompensation`	$278.48K	USD	2 Qtrs
Equity based employee compensation expense	`ShareBasedCompensation`	$122.81K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$150.00K	USD	2 Qtrs
Grant receivable	`IncreaseDecreaseInOtherReceivables`	$-223.54K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$607.50K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$267.36K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$36.79K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-61.52K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-78.41K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-29.93K	USD	2 Qtrs
Accrued interest payable to shareholders	`IncreaseDecreaseInDueToOfficersAndStockholders`	$39.69K	USD	2 Qtrs
Accrued interest payable to shareholders	`IncreaseDecreaseInDueToOfficersAndStockholders`	$-172.55K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$92.94K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-37.34K	USD	2 Qtrs
Deferred grant revenue	`IncreaseDecreaseInDeferredRevenue`	$-143.54K	USD	2 Qtrs
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.29M	USD	2 Qtrs
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-585.49K	USD	2 Qtrs
Acquisition of patents and trademarks	`PaymentsToAcquireIntangibleAssets`	$84.88K	USD	2 Qtrs
Acquisition of patents and trademarks	`PaymentsToAcquireIntangibleAssets`	$552.12K	USD	2 Qtrs
Acquisition of office furniture and fixtures	`PaymentsToAcquireFurnitureAndFixtures`	$4.79K	USD	2 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-556.91K	USD	2 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-84.88K	USD	2 Qtrs
Payment of deferred private placement costs	`PaymentsOfStockIssuanceCosts`	$53.45K	USD	2 Qtrs
Payment on demand loan	`RepaymentsOfShortTermDebt`	$7.38K	USD	2 Qtrs
Proceeds from issuance of notes and warrants	`ProceedsFromIssuanceOfWarrants`	$450.00K	USD	2 Qtrs
Payments on notes payable to shareholders	`RepaymentsOfRelatedPartyDebt`	$4.39K	USD	2 Qtrs
Payments on notes payable to shareholders	`RepaymentsOfRelatedPartyDebt`	$393.27K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$410.00K	USD	2 Qtrs
Net proceeds from January 25, 2011 private placement	`ProceedsFromIssuanceOrSaleOfEquity`	$3.35M	USD	2 Qtrs
Net payments to related party	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-90.40K	USD	2 Qtrs
Net payments to related party	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-21.27K	USD	2 Qtrs
Net advances from (payments to) officers	`ProceedsFromPaymentsForOtherFinancingActivities`	$-930.00	USD	2 Qtrs
Net advances from (payments to) officers	`ProceedsFromPaymentsForOtherFinancingActivities`	$1.31K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.93M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$703.45K	USD	2 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$33.08K	USD	2 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$86.27K	USD	2 Qtrs
Cash - beginning of period	`Cash`	$86.58K	USD	Point-in-time
Cash - beginning of period	`Cash`	$158.00	USD	Point-in-time
Cash - beginning of period	`Cash`	$33.24K	USD	Point-in-time
Cash - beginning of period	`Cash`	$310.00	USD	Point-in-time
Cash - end of period	`Cash`	$86.58K	USD	Point-in-time
Cash - end of period	`Cash`	$158.00	USD	Point-in-time
Cash - end of period	`Cash`	$33.24K	USD	Point-in-time
Cash - end of period	`Cash`	$310.00	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$7.60K	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$189.74K	USD	2 Qtrs
Payment of accounts payable for patent costs	`PaymentOfAccountsPayableForPatentCosts`	$500.00K	USD	2 Qtrs
Payment of accounts payable for deferred private placement costs	`PaymentOfAccountsPayableForDeferredPrivatePlacementCosts`	$526.13K	USD	2 Qtrs
Accounts payable converted to promissory notes	`ConversionOfAccountsPayableToNotePayable`	$587.00K	USD	2 Qtrs
Supplemental Accounts Payable, Total	`SupplementalAccountsPayable`	$1.61M	USD	2 Qtrs
Deferred private placement costs charged to contributed capital	`DeferredPrivatePlacementCostsChargedToContributedCapital`	$587.13K	USD	2 Qtrs
Conversion of member note to common shares and warrants	`DebtConversionOriginalDebtAmount1`	$31.31K	USD	2 Qtrs
Conversion of member note to common shares and warrants	`DebtConversionOriginalDebtAmount1`	$614.07K	USD	2 Qtrs
Issuance of warrants as derivative liability instruments and reduction of capital in excess of par value	`IssuanceOfDerivativeLiabilityInstrumentsAndReductionOfAdditionalPaidInCapital`	$3.06M	USD	2 Qtrs
Patent and trademark additions included in accounts payable	`PatentAndTrademarkAdditionsIncludedInAccountsPayable`	$16.37K	USD	2 Qtrs
Deferred private placement cost additions included in accounts payable	`DeferredPrivatePlacementCostAdditionsIncludedInAccountsPayable`	$209.18K	USD	2 Qtrs

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.73M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time
Distribution of 5,000,000 warrants for common stock, exercise price of $3.00 per share	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$-1.55M	USD	2 Qtrs
Common Shares issued in January 25, 2011 private placement	`StockIssuedDuringPeriodValueNewIssues`	$2.39M	USD	2 Qtrs
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$278.48K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-1.75M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-1.10M	USD	1 Quarter
Net loss	`ProfitLoss`	$-385.10K	USD	1 Quarter
Net loss	`ProfitLoss`	$-690.12K	USD	2 Qtrs
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.73M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time

Comprehensive Income 2 line items

Line Item	Tag	Value	Unit	Period
Distribution of warrants for common stock, warrants	`NumberOfCommonStockWarrantsDistributedToShareholders`	5.00M	shares	2 Qtrs
Distribution of warrants for common stock, exercise price	`InvestmentWarrantsExercisePrice`	$3.00	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.